Physician profile
Hanan Morcos
NPI 1306037171
$6,365.49
in general payments reported to CMS, 2019-2025
46 companies · $1,244 in 2025
The $1,244 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,150 · 2020: $614 · 2021: $263 · 2022: $386 · 2023: $1,867 · 2024: $842 · 2025: $1,244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,116 · Travel and Lodging: $738 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,116.33 |
| Travel and Lodging | $737.78 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,442.57 | 2023-2025 | Micra, Cobalt Dr Mri Surescan, Corevalve Evolut R |
| Amgen INC. | $534.46 | 2019-2025 | Repatha, Repatha |
| Biotronik INC. | $484.64 | 2019-2021 | |
| Boston Scientific Corporation | $426.35 | 2022-2025 | General - Therapies, Lux-Dx Insertable Cardiac Monitor, General - Tachy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $408.80 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $314.46 | 2023-2025 | Farxiga |
| Merck Sharp & Dohme LLC | $307.67 | 2021-2025 | Verquvo |
| Novo Nordisk INC | $295.02 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Janssen Pharmaceuticals, INC | $227.37 | 2019-2024 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $167.14 | 2023-2024 | Inpefa |
| Medtronic Vascular, INC. | $146.82 | 2019 | |
| Abbott Laboratories | $141.52 | 2019-2024 | Accent, Merlin@Home |
| Kestra Medical Technology Services, INC. | $134.13 | 2023-2025 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $131.58 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $130.99 | 2024-2025 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hanan Morcos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.